Vita, Maria Gabriella
 Distribuzione geografica
Continente #
NA - Nord America 2.054
EU - Europa 1.605
AS - Asia 1.456
SA - Sud America 284
AF - Africa 45
OC - Oceania 4
Totale 5.448
Nazione #
US - Stati Uniti d'America 1.967
SG - Singapore 640
DE - Germania 534
CN - Cina 360
IT - Italia 322
BR - Brasile 236
SE - Svezia 201
VN - Vietnam 164
FR - Francia 154
UA - Ucraina 94
GB - Regno Unito 60
IN - India 54
FI - Finlandia 53
CA - Canada 52
IE - Irlanda 49
BD - Bangladesh 45
ID - Indonesia 38
HK - Hong Kong 32
NL - Olanda 31
JP - Giappone 30
RU - Federazione Russa 23
BE - Belgio 19
AR - Argentina 17
KR - Corea 17
TR - Turchia 16
MX - Messico 15
PL - Polonia 13
CI - Costa d'Avorio 12
ES - Italia 12
AT - Austria 11
EC - Ecuador 10
IQ - Iraq 10
KE - Kenya 8
SA - Arabia Saudita 8
CL - Cile 7
ZA - Sudafrica 7
IR - Iran 6
MA - Marocco 6
MY - Malesia 6
UZ - Uzbekistan 6
NO - Norvegia 5
TT - Trinidad e Tobago 5
VE - Venezuela 5
AU - Australia 4
LT - Lituania 4
CO - Colombia 3
DO - Repubblica Dominicana 3
EG - Egitto 3
PH - Filippine 3
PY - Paraguay 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
GR - Grecia 2
IL - Israele 2
JO - Giordania 2
KZ - Kazakistan 2
LU - Lussemburgo 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BW - Botswana 1
BZ - Belize 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
GT - Guatemala 1
HU - Ungheria 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
KY - Cayman, isole 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MN - Mongolia 1
MR - Mauritania 1
MT - Malta 1
NG - Nigeria 1
OM - Oman 1
PK - Pakistan 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
TW - Taiwan 1
ZW - Zimbabwe 1
Totale 5.448
Città #
Singapore 362
Chandler 237
San Jose 211
Ashburn 196
Beijing 79
Rome 71
Los Angeles 69
Ho Chi Minh City 63
New York 60
Dallas 53
Jacksonville 53
San Mateo 53
Ann Arbor 49
Dublin 47
Hanoi 41
Munich 40
Hefei 39
Lauterbourg 39
Milan 39
Nürnberg 35
Wilmington 35
Frankfurt am Main 33
Jakarta 33
Boston 30
Hong Kong 29
Houston 29
Tokyo 29
Council Bluffs 26
Dearborn 26
Chicago 24
Nanjing 24
Marseille 23
Montreal 23
Cattolica 22
Nanchang 22
São Paulo 20
Boardman 19
Brussels 19
Helsinki 19
Buffalo 17
Santa Clara 17
Lawrence 16
The Dalles 16
Fairfield 15
Woodbridge 15
Detroit 14
Seoul 14
Kent 13
Redwood City 13
Seattle 13
Toronto 13
Abidjan 12
Orem 12
Princeton 12
Amsterdam 11
Moscow 11
Paris 11
Turku 11
Brooklyn 10
Chennai 10
Hangzhou 10
Brasília 9
Haiphong 9
Kunming 9
Salt Lake City 9
Sittard 9
Tianjin 9
Augusta 8
Bremen 8
Elk Grove Village 8
Guangzhou 8
Nuremberg 8
Rio de Janeiro 8
Shenyang 8
Tampa 8
Warsaw 8
Changsha 7
Curitiba 7
Jiaxing 7
London 7
Portsmouth 7
Tukwila 7
Atlanta 6
Berlin 6
Chiari 6
Da Nang 6
Denver 6
Düsseldorf 6
Hebei 6
Leawood 6
Nairobi 6
Ottawa 6
Poplar 6
Pune 6
San Francisco 6
Stockholm 6
Vienna 6
Zhengzhou 6
Baghdad 5
Bologna 5
Totale 2.881
Nome #
Difference in striatal dopamine transporter availability and psychiatric symptoms in Parkinson's disease subtypes: 123I-FP-CIT SPECT results 217
Does Semantic Memory Impairment in Amnestic MCI with Hippocampal Atrophy Conform to a Distinctive Pattern of Progression? 210
Does semantic memory impairment in amnestic MCI with hippocampal atrophy conform to a distinctive pattern of progression? 208
Patterns of Cognitive Decline and Rates of Conversion to Dementia in Patients with Degenerative and Vascular Forms of MCI 197
Neuroacanthocytosis Syndromes in an Italian Cohort: Clinical Spectrum, High Genetic Variability and Muscle Involvement 188
Cerebellar degeneration associated with mGluR1 autoantibodies as a paraneoplastic manifestation of prostate adenocarcinoma 184
Human brain networks in cognitive decline: a graph theoretical analysis of cortical connectivity from EEG data 179
Elevated serum Neurofilament Light chain (NfL) as a potential biomarker of neurological involvement in Myotonic Dystrophy type 1 (DM1) 174
R208H-129VV haplotype in the prion protein gene: phenotype and neuroimaging of a patient with genetic Creutzfeldt-Jakob disease. 174
Standardization, Clinical Validation, and Typicality Norms of a New Test Assessing Semantic Verbal Fluency 162
Prevalence and Clinical Correlates of Cerebrovascular Alterations in Fabry Disease: A Cross-Sectional Study 160
ARE RAW SCORES ON MEMORY TESTS BETTER THAN AGE- AND EDUCATION-ADJUSTED SCORES FOR PREDICTING PROGRESSION FROM AMNESIC MILD COGNITIVE IMPAIRMENT TO AD ? 157
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 156
Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: results of a phase IIb double-blind study of salbutamol 156
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication. 156
Cognitive and behavioral determinants of psychotic symptoms in Alzheimer's disease 154
Neuroradiology of human prion diseases, diagnosis and differential diagnosis. 154
Nucleoporin 153 deficiency in adult neural stem cells defines a pathological protein-network signature and defective neurogenesis in a mouse model of AD 152
Cognitive impairment in myotonic dystrophy type 1 (DM1) : A longitudinal follow-up study 151
Human brain networks in cognitive decline: a graph theoretical analysis of cortical connectivity from EEG data 143
Performance of Fully-Automated High-Throughput Plasma Biomarker Assays for Alzheimer’s Disease in Amnestic Mild Cognitive Impairment Subjects 139
Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy 131
Patterns of neuropsychological impairment in MCI patients with small subcortical infarcts or hippocampal atrophy 130
Predicting progression of amnesic MCI: The integration of episodic memory impairment with perfusion SPECT 129
Structural and functional alterations of neurons derived from sporadic Alzheimer’s disease hiPSCs are associated with downregulation of the LIMK1-cofilin axis 127
Predicting progression of amnesic MCI: The integration of episodic memory impairment with perfusion SPECT 123
Neurological Erdheim-Chester Disease Manifesting with Subacute or Progressive Cerebellar Ataxia: Novel Case Series and Review of the Literature 117
Associations Between Free and Cued Selective Reminding Test and Cerebrospinal Fluid Biomarkers in Amnestic Mild Cognitive Impairment 116
Visual hallucinations and pontine demyelination in a child: possible REM dissociation? 112
Subclinical epileptiform activity during sleep in Alzheimer's disease and mild cognitive impairment 108
Selective impairment of living things and musical instruments on a verbal 'Semantic Knowledge Questionnaire' in a case of apperceptive visual agnosia 95
Acromegaly can be cured by first-line pasireotide treatment? 92
Cerebrospinal fluid neurofilament light chain and total-tau as biomarkers of neurodegeneration in Alzheimer's disease and frontotemporal dementia 92
Performance of Fully-Automated High-Throughput Plasma Biomarker Assays for Alzheimer’s Disease in Amnestic Mild Cognitive Impairment Subjects 91
Cerebrospinal fluid neurofilament light chain and total-tau as biomarkers of neurodegeneration in Alzheimer's disease and frontotemporal dementia 88
Levodopa-Carbidopa Intestinal Gel in a Pediatric Parkinsonism-plus Syndrome 88
Psychotic Symptoms in Alzheimer's disease and 5-HTTLPR polymorphism of the serotonin transporter gene: evidence for an association 85
Cognitive impairment in myotonic dystrophy type 1 (DM1) : A longitudinal follow-up study. 78
Different Markers of Semantic–Lexical Impairment Allow One to Obtain Different Information on the Conversion from MCI to AD: A Narrative Review of an Ongoing Research Program 76
RAB32 mutation in Parkinson's disease [2] 36
Predictive value of cerebrospinal fluid Alzheimer's disease biomarkers and neuropsychological measures for cognitive and motor outcomes in Parkinson's disease 8
Very late-onset Krabbe disease with concomitant dementia: case description and a critical review of the literature 7
Totale 5.500
Categoria #
all - tutte 20.736
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.736


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 0 0 8
2021/2022294 13 17 15 16 20 22 12 57 16 20 33 53
2022/2023659 90 90 51 104 39 82 36 51 74 10 16 16
2023/2024292 12 77 7 11 6 38 11 26 1 18 37 48
2024/2025816 9 27 53 45 69 23 27 41 101 92 188 141
2025/20262.249 288 73 208 245 327 100 407 116 137 158 104 86
Totale 5.500